Please read this carefully:

2) The OncoPet RECAF™ test has NOT been approved by the U.S. Food and Drug Administration, the U.S. Department of Agriculture, or any other regulatory organization in any country for use in the diagnosis of cancer in any species and there is no assurance when or if such approval will be forthcoming.

3) The information provided on this web site is for general information purposes only and is not intended as medical or veterinarian advice. Medical or veterinary advice regarding companion animal cancer and its appropriate treatment should only be obtained from a qualified licensed veterinarian.

4) Sensitivity and Specificity of the OncoPet RECAF™ test: Some normal animals may test positive for cancer (false positives) and some animals with cancer may test negative using the OncoPet RECAF™ test (false negatives). Depending on the type of cancer, the number of false negatives can be as high as 25% (75% sensitivity) and the number of false positives among normal dogs can be as high as 10% (90% specificity). It should be kept in mind that these figures are calculated from experiments done on the most common types of cancers in companion animals and therefore they may be different for other types of cancers for which sensitivity values might not have been assessed yet. Some acute inflammatory lesions produce very high levels of circulating RECAF™ and therefore samples from animals suspected of having an inflammatory process or infection should not be sent for testing.

5) The calculation of the positive/negative cutoff value and the sensitivity and specificity of the test are estimated from a relatively small number of samples and might not reflect the values obtained from a larger number of samples and might require adjustment as the number of samples increases and more types of cancers are studied. The efficacy of screening larger populations has yet to be determined. An elevated RECAF™ level can occur in some non-malignant neoplasms as well as in advanced and terminal cancer, where the benefits of using the test are nil. Acute infections can sometimes trigger an elevation of RECAF™ levels and therefore these should be eliminated by other diagnostic procedures.

6) The OncoPet RECAF™ test is NOT, by itself, conclusive of the presence or absence of cancer and its results can only be assessed as an aid in the detection or monitoring of cancer in relation to the history, medical signs, symptoms and the overall condition of the animal.

7) As with other cancer markers, the chance of having cancer varies with the amount of circulating RECAF™. Thus, an animal with high RECAF™ values is more likely to have cancer than an animal with low RECAF™ values. The error in estimating whether a patient is positive or negative for cancer is highest around the cutoff value used as stated in the report to the veterinarian.

8) None of OncoPet Diagnostics, Inc., BioCurex, Inc. Pacific Biosciences Research Centre Inc., or any of their respective, directors, officers and employees, will be liable for the content of the reported results or for the consequences of any actions taken on the basis of the information provided. Any reliance you place on such information is strictly at your own risk.

9) OncoPet Diagnostics Inc. does not accept samples sent by any other person than a qualified veterinarian. The company reserves the right not to test samples sent for testing and in that case, it is under no obligation to return the sample or other collection material.

10) Guarantee: OncoPet Diagnostics, Inc. will provide an OncoPet RECAF™ test for free for each false positive or false negative as established upon receiving a contradictory report from an independent pathologist.

11) Except as set forth in the preceding sentence, OncoPet Diagnostics, Inc. offers no guaranties of any type and does not assume any responsibility for the decisions made by the professional in charge of the patient or the animal care giver or the owner after receiving the results of an OncoPet RECAF™ test.

12) Individuals, companies, not-for-profit organizations and any other entity or person requesting an OncoPet RECAF™ test acknowledge that the sole liability of the company and those involved in testing the samples is limited to the list price value of one test..

Back to Top